New drug targets hidden heart risk in first human test
Disease control
Completed
This was the first study in people to test the safety of a new drug called Kylo-11. It involved 71 healthy volunteers to see how their bodies handled the drug and if it lowered a specific blood marker linked to heart disease risk. The main goal was to check for side effects and s…
Phase: PHASE1 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC